| CANDRIAM EQUITIES L BIOTECHNOLOGY R-H CAP EUR | BIOTECNOLOGÍA | 285,410000 | 13/02/2026 | 1,69% | 50,27% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY V CAP USD | BIOTECNOLOGÍA | 2.479,742033 | 13/02/2026 | 1,07% | 42,82% | *** |
| CANDRIAM EQUITIES L EMERGING MARKETS C CAP EUR | RVI EMERGENTES | 1.348,950000 | 13/02/2026 | 11,14% | 52,07% | **** |
| CANDRIAM EQUITIES L EMERGING MARKETS C DIS EUR | RVI EMERGENTES | 834,270000 | 13/02/2026 | 11,14% | 40,94% | ** |
| CANDRIAM EQUITIES L EMERGING MARKETS C-H CAP USD | RVI EMERGENTES | 247,167425 | 13/02/2026 | 10,40% | 44,45% | *** |
| CANDRIAM EQUITIES L EMERGING MARKETS I CAP EUR | RVI EMERGENTES | 1.634,700000 | 13/02/2026 | 11,20% | 56,90% | **** |
| CANDRIAM EQUITIES L EMERGING MARKETS I-H CAP USD | RVI EMERGENTES | 1.733,999326 | 13/02/2026 | 10,54% | · | ND |
| CANDRIAM EQUITIES L EMERGING MARKETS N CAP EUR | RVI EMERGENTES | 1.201,970000 | 13/02/2026 | 11,10% | 50,66% | *** |
| CANDRIAM EQUITIES L EMERGING MARKETS R CAP EUR | RVI EMERGENTES | 233,230000 | 13/02/2026 | 11,27% | 56,36% | **** |
| CANDRIAM EQUITIES L EMERGING MARKETS V CAP EUR | RVI EMERGENTES | 1.687,710000 | 13/02/2026 | 11,33% | 58,86% | **** |